» Articles » PMID: 39677564

Efficacy and Safety of One Shot of Hyaluronic Acid in Hip Osteoarthritis: Postmarketing Clinical Follow-Up for Real-World Evidence

Overview
Publisher Dove Medical Press
Specialty Rheumatology
Date 2024 Dec 16
PMID 39677564
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This study aims to evaluate the real-world efficacy and safety of intra-articular (IA) hyaluronic acid (HA) injections in patients with hip osteoarthritis (OA). Given the increasing burden of hip osteoarthritis and limited evidence supporting viscosupplementation in this context, this research aims to provide valuable insights under real clinical practice conditions.

Patients And Methods: An observational, cross-sectional and retrospective study was conducted in a cohort of patients with hip OA treated with a single injection of HA (Adant One, Meiji Pharma Spain, Spain) from January 2021 to December 2022. Data on patient demographics, clinical characteristics, and treatment outcomes were collected. Efficacy regarding pain relief and/or function improvement was assessed at 6 months using the Visual Analogue Scale (VAS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Data were pseudonymized. The study was approved by the Research Ethics Committee of the Autonomous Community of Aragon (CEICA).

Results: The study included 40 patients with a mean age of 62.8 years, with 72.5% being female. Significant improvement was observed six-months post-treatment: 25% and 18.5% reduction in pain (VAS and WOMAC, respectively), 11.6% improvement in function (WOMAC), 7.4% improvement in stiffness (WOMAC), and 13.6% improvement in total WOMAC. No adverse events were reported.

Conclusion: A single injection of IA HA significantly improved pain and function in patients with hip OA. These findings support the use of viscosupplementation for hip OA management and underscore the need for further studies to confirm these results and assess the long-term benefits of IA HA in hip OA.

References
1.
Phillips M, Bhandari M, Grant J, Bedi A, Trojian T, Johnson A . A Systematic Review of Current Clinical Practice Guidelines on Intra-articular Hyaluronic Acid, Corticosteroid, and Platelet-Rich Plasma Injection for Knee Osteoarthritis: An International Perspective. Orthop J Sports Med. 2021; 9(8):23259671211030272. PMC: 8414628. DOI: 10.1177/23259671211030272. View

2.
Concoff A, Niazi F, Farrokhyar F, Alyass A, Rosen J, Nicholls M . Delay to TKA and Costs Associated with Knee Osteoarthritis Care Using Intra-Articular Hyaluronic Acid: Analysis of an Administrative Database. Clin Med Insights Arthritis Musculoskelet Disord. 2021; 14:1179544121994092. PMC: 7989120. DOI: 10.1177/1179544121994092. View

3.
Altman R, Hackel J, Niazi F, Shaw P, Nicholls M . Efficacy and safety of repeated courses of hyaluronic acid injections for knee osteoarthritis: A systematic review. Semin Arthritis Rheum. 2018; 48(2):168-175. DOI: 10.1016/j.semarthrit.2018.01.009. View

4.
Maheu E, Rannou F, Reginster J . Efficacy and safety of hyaluronic acid in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016; 45(4 Suppl):S28-33. DOI: 10.1016/j.semarthrit.2015.11.008. View

5.
Bernetti A, Agostini F, Paoloni M, Raele M, Fari G, Megna M . Could Hyaluronic Acid Be Considered as a Senomorphic Agent in Knee Osteoarthritis? A Systematic Review. Biomedicines. 2023; 11(10). PMC: 10604344. DOI: 10.3390/biomedicines11102858. View